Published in Indian J Endocrinol Metab on May 01, 2013
Congenital adrenal hyperplasia. N Engl J Med (2003) 4.05
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Prenatal glucocorticoids and long-term programming. Eur J Endocrinol (2004) 2.28
[Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms]. Helv Paediatr Acta (1954) 1.72
Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet (2005) 1.64
Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update (2004) 1.46
Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest (2007) 1.28
Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab (2001) 1.23
Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab (2006) 1.19
Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf) (2010) 1.02
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr (1984) 1.00
Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab (1998) 0.99
Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol (2008) 0.92
Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol (1999) 0.89
Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint. J Clin Endocrinol Metab (2012) 0.88
Prenatal treatment of congenital adrenal hyperplasia-not standard of care. J Genet Couns (2012) 0.85
Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol (2012) 0.83
Congenital adrenal hyperplasia: Results of medical therapy on appearance of external genitalia. J Pediatr Urol (2010) 0.82
Endocrine Society Congenital Adrenal Hyperplasia Guidelines: great content but how to deliver? Clin Endocrinol (Oxf) (2012) 0.81
Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study. Acta Paediatr (2011) 0.80
Impact of molecular genetics on congenital adrenal hyperplasia management. Sex Dev (2010) 0.78
Apparent male gender identity in a patient with complete androgen insensitivity syndrome. Arch Sex Behav (2009) 2.01
Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab (2010) 1.21
Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur Radiol (2011) 1.10
5 α-reductase type 2 deficiency - response to dihydrotestosterone gel: correspondence. Indian J Pediatr (2013) 1.08
Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma. Eur J Nucl Med Mol Imaging (2013) 1.07
⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin. Clin Nucl Med (2012) 1.02
Internal jugular vein: Peripheral vein adrenocorticotropic hormone ratio in patients with adrenocorticotropic hormone-dependent Cushing's syndrome: Ratio calculated from one adrenocorticotropic hormone sample each from right and left internal jugular vein during corticotrophin releasing hormone stimulation test. Indian J Endocrinol Metab (2013) 0.98
Fertility among women with classical congenital adrenal hyperplasia: report of seven cases where treatment was started after 9 years of age. Gynecol Endocrinol (2008) 0.97
Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Gynecol Endocrinol (2008) 0.91
Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clin Endocrinol (Oxf) (2005) 0.89
Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes. Clin Nucl Med (2015) 0.88
Insulin sensitivity and β-cell function in normoglycemic offspring of individuals with type 2 diabetes mellitus: Impact of line of inheritance. Indian J Endocrinol Metab (2012) 0.87
Diagnosis and management of classical congenital adrenal hyperplasia. Steroids (2013) 0.87
Hypokalemic paralysis as a presenting manifestation of primary Sjögren's syndrome: A report of two cases. Indian J Endocrinol Metab (2012) 0.86
Evaluation of (68)Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging (2015) 0.83
Internal jugular vein adrenocorticotropic hormone estimation for diagnosis of adrenocorticotropic hormone-dependent Cushing's syndrome: Ultrasound-guided direct jugular vein sample collection. Indian J Endocrinol Metab (2012) 0.83
Morning cortisol is lower in obese individuals with normal glucose tolerance. Diabetes Metab Syndr Obes (2011) 0.82
Type 2 diabetes increases risk for obesity among subsequent generations. Diabetes Technol Ther (2009) 0.82
Molecular diagnosis of 5alpha-reductase-2 gene mutation in two Indian families with male pseudohermaphroditism. Asian J Androl (2007) 0.81
Demographic, breast-feeding, and nutritional trends among children with type 1 diabetes mellitus. Indian J Endocrinol Metab (2011) 0.81
Insulinoma: reversal of brain magnetic resonance imaging changes following resection. Neurol India (2008) 0.81
Gender identity of children and young adults with 5alpha-reductase deficiency. J Pediatr Endocrinol Metab (2008) 0.81
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor. Eur J Nucl Med Mol Imaging (2014) 0.80
Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus. Diabetes Technol Ther (2010) 0.80
Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture. J Pediatr Endocrinol Metab (2013) 0.80
Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia. Indian J Endocrinol Metab (2012) 0.78
Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes. Diabetes Technol Ther (2008) 0.78
Behavioral aggressiveness in boys with sexual precocity. Indian J Endocrinol Metab (2012) 0.77
Morning plasma cortisol is low among obese women with polycystic ovary syndrome. Gynecol Endocrinol (2013) 0.77
Vitiligo, hypothyroidism and cardiomyopathy. Indian J Endocrinol Metab (2012) 0.75
Fertility in patients with 5-alpha-reductase-2 deficiency. Fertil Steril (2011) 0.75
Development of Graves' disease after long-standing hypothyroidism on treatment, with acute toxicity to thionamides and lithium. BMJ Case Rep (2012) 0.75
Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages. Indian J Endocrinol Metab (2012) 0.75
Sex of rearing seems to exert a powerful influence on gender identity in the absence of strong hormonal influence: report of two siblings with PAIS assigned different sex of rearing. J Pediatr Endocrinol Metab (2011) 0.75
Novel nucleotide insertions in two unrelated Indian patients with 5α reductase 2 deficiency leading to premature termination of SRD5A2 enzyme. Steroids (2013) 0.75
Mother-to-son transmission of a luteinizing hormone receptor activating mutation in a prepubertal child with testotoxicosis. J Pediatr Endocrinol Metab (2009) 0.75
Recovery of β-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients. Diabetes Technol Ther (2011) 0.75
Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis. Gynecol Endocrinol (2012) 0.75